Key facts
- It has raised $4.3M across 1 recorded rounds; the latest was Seed Round ($4.3M) in May 2023.
- Notable investors include University Hospitals Ventures.
- ValCor Cath has filed 2 Form Ds with the SEC since 2023, most recently Aug 2025 ($4.3M sold to 52 investors).
- Status: Privately Held (backing).
Investors
1Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for ValCor Cath
Create free account
No card required
Funding rounds
1 roundsAbout ValCor Cath
Developer of a medical device designed for cardiac surgeries. The company offers a two-in-one guided catheter for cardiac surgical procedures, enabling patients to get treatment for their heart conditions.
- Sector
- Healthcare
- HQ
- Ottawa Hills, OH, United States
- Founded
- 2020
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
ValCor Cath doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in ValCor Cath shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on ValCor Cath in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.